Banco Btg Pactual S.A. Solid Biosciences Inc. Put Options Transaction History

Banco Btg Pactual S.A.

  • $592 Million
  • Q1 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
96
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $44.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Banco Btg Pactual S.A. Portfolio

Follow Banco Btg Pactual S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Btg Pactual S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Btg Pactual S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email